Cannabidiol (Epidyolex®) accepted for use within NHS Scotland for Lennox-Gastaut syndrome
Cannabidiol oral solution is approved for use as adjunctive therapy of seizures associated with Lennox-Gastaut syndrome, in conjunction with clobazam, for patients 2 years of age and older.
Source:
Scottish Medicines Consortium